App-Quantinova.ai

Vascular response to paclitaxiel-eluting nitinol self-expanding stent in superficial femoral artery lesions: Angioscopic findings at 2, 6 and 12 months after implantation

Toshiro Shinke - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Drug-Eluting Devices in Femoropopliteal Disease: Trends of Use and Patient Outcomes

Daniel Ortiz - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-implant Antithrombotic Therapy

Kasper Korsholm - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

Safety, Clinical Performance and multi-modality imaging data of the Drug Eluting Absorbable Metal Scaffold in the Treatment of Subjects with de Novo Lesions in Native Coronary Arteries at 12-month follow-up-BIOSOLVE-II

Huseyin Ince - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Nitroglycerin

Prospective, Multi-Center Evaluation of the DESolve Novolimus-Eluting Bioresorbable Coronary Scaffold: Imaging Outcomes and 4-Year Clinical and Imaging Results

Stefan Verheye - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

In hospital and one month outcomes of 983 patients implanted with bioresorbable vascular scaffolds for Acute Coronary Syndroms ; subgroup of the prospective, all comers, controlled, multicenter, FRANCE ABSORB Registry.

Joel Sainsous - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

Bivalirudin

LEADERS FREE OAC : Biolimus A9 coated versus bare metal stents in patients requiring oral anticoagulation. A pre-specified subgroup analysis of the LEADERS FREE trial

Didier Carrie - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Biolimus A9

Impact of Lesion Length on 1-year Outcomes of Absorb Bioresorbable Vascular Scaffolds

Rony Lahoud - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Long-term clinical outcomes of patients treated with everolimus-eluting bioresorbable scaffolds during daily practice 2-year results from the ISAR-ABSORB Registry

Jens Wiebe - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Overlapping Bioresorbable Coronary Devices: Immediate Results and 6-month Follow-up of the REPARA Registry

Felipe Hernandez - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

1-year Clinical Outcomes of Absorb Bioresorbable Vascular Scaffold (BVS) in Diabetic and Non-Diabetic Patients: Patient-Level Pooled Analysis from the ABSORB Randomized Trials

Ariel Furer - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Everolimus

Comparative Efficacy and Safety of Coronary Stents in Diabetic Patients With and Without Insulin Treatment: A pooled patient level analysis from 17 randomized trials

Jaya Chandrasekhar - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Effects of dual antiplatelet therapy cessation among patients with diabetes mellitus after PCI with DES

Michela Faggioni - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

A Randomized Comparison of The Second Generation Biodegradable Polymer Sirolimus-eluting Stent (EXCEL-II) and The First Generation EXCEL-I stent in Patients with De novo Coronary Lesions: Clinical and Angiographic Outcomes of the CREDIT II Trial

Yaling Han - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Final 5 year results from the COMPARE II trial: comparison between the durable polymer coated everolimus-eluting Xience/Promus stent and the biodegradable polymer coated biolimus-eluting Nobori stent in all comer population

Pieter Smits - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

The NIREUS Randomized Trial: 1-Year Results of the BioNIR Ridaforolimus-Eluting Coronary Stent System (BioNIR) EUropean Angiography Study

Pieter Smits - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Ridaforolimus

Short and medium-term clinical outcome of amphilimus polymer-free drug-eluting stent in diabetic patients: An all-comers multicenter spanish registry. (Control-8 registry)

Antonio Gomez Menchero - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Clopidogrel bisulfate

Course of early subclinical leaflet thrombosis after transcatheter aortic valve replacement with or without oral anticoagulation

Philipp Ruile - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Relative Efficacy and Safety of oral P2Y12 inhibitors in Acute coronary syndrome: An Updated Network Meta-Analysis of Randomized Trials

Rahman Shah - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Outcomes after Revascularization with Sirolimus-eluting and Birolimus-Eluting Stents with biodegradable polymer In Patients with Acute Coronary Syndromes. From the SORT OUT VII Trial

christian oliver fallesen - Transcatheter Cardiovascular Therapeutics (TCT) , 2016

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Rapacan

Filters

7277 Abstracts